Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Unapproved Zika Tests Attract FDA 'Untitled' Letters

This article was originally published in The Gray Sheet

Executive Summary

Two companies and two hospitals are marketing Zika virus diagnostics without FDA go-ahead, the agency said in letters that asked the organizations for data supporting their assays.



Related Companies